N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 1, 2002, Pages 99-103

  Agundez J A G ^a   Ladero, José M ^a   Olivera, M ^a   Lozano, L ^a   Fernandez Arquero M ^a   De la Concha, E G ^a   Diaz Rubio M ^a   Benitez J ^a  

^a NONE

Author keywords

Alcoholic liver disease; Hepatocellular carcinoma; N acetyltransferase 2; Polymorphisms

Indexed keywords

ACYLTRANSFERASE; ARYLAMINE ACETYLTRANSFERASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ALCOHOL METABOLISM; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

EID: 0036146981     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202753387437     Document Type: Article

References (22)

1. Prevalence of chronic liver disease in the general population of northern Italy: The Dionysus study
2. The inheritance of alcoholic liver disease
3. Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men
4. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: Effect on age of presentation and dependence on alcohol dehydrogenase genotype
5. RsaI polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease
6. Genetic polymorphisms of cytochrome p4502E1 and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a white population: A study and literature review, including meta-analysis
7. Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients
8. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
9. Acetylation pharmacogenetics
10. Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population
11. N-acetyltransferase-2, glutathione S-transferase M1, alcohol dehydrogenase, and cytochrome P450IIE1 genotypes in alcoholic liver cirrhosis: A case-control study
12. Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population
13. Lung cancer and mutations at the polymorphic NAT2 gene locus
14. NAT2 genotype of patients with hepatocellular carcinoma
15. Molecular genetics of human polymorphic N-acetyltransferase: Enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes
16. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltrasferase (NAT2) alleles
17. Metabolic activation of N-hydroxyarylamines and N-hydroxyarilamides by 16 recombinant human NAT2 allozymes: Effects of 7 specific NAT2 nucleic acid substitutions
18. Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: Correlation with phenotypic activity
19. Novel human N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype
20. Acetylation as an indicator of risk
21. Infección por los virus de la hepatitis B y C en pacientes con carcinoma hepatocelular
22. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen